Sabra Healthcare Number Of Shares Shorted vs. Shares Outstanding

SBRA Stock  USD 17.94  0.15  0.84%   
Based on the measurements of profitability obtained from Sabra Healthcare's financial statements, Sabra Healthcare REIT may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Sabra Healthcare's ability to earn profits and add value for shareholders. At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.11, whereas Days Sales Outstanding is forecasted to decline to 55.31. At present, Sabra Healthcare's Accumulated Other Comprehensive Income is projected to increase significantly based on the last few years of reporting. The current year's Change To Netincome is expected to grow to about 256 M, whereas Operating Income is forecasted to decline to about 163.2 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.390.4157
Notably Down
Slightly volatile
Operating Profit Margin0.470.3421
Significantly Up
Pretty Stable
For Sabra Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sabra Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sabra Healthcare REIT utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sabra Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sabra Healthcare REIT over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sabra Healthcare REIT Shares Outstanding vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Sabra Healthcare's current stock value. Our valuation model uses many indicators to compare Sabra Healthcare value to that of its competitors to determine the firm's financial worth.
Sabra Healthcare REIT is rated second in number of shares shorted category among its peers. It is rated fifth in shares outstanding category among its peers creating about  13.18  of Shares Outstanding per Number Of Shares Shorted. As of December 11, 2024, Common Stock Shares Outstanding is expected to decline to about 131.1 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sabra Healthcare's earnings, one of the primary drivers of an investment's value.

Sabra Shares Outstanding vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Sabra Healthcare

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
17.96 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Sabra Healthcare

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
236.59 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Sabra Shares Outstanding Comparison

Sabra Healthcare is currently under evaluation in shares outstanding category among its peers.

Sabra Healthcare Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Sabra Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sabra Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Sabra Healthcare's change in net profit over the period of time. It can combine multiple indicators of Sabra Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income23.7 M24.9 M
Operating Income221.5 M163.2 M
Income Before Tax15.8 M15 M
Net Income13.8 M13.1 M
Income Tax ExpenseM1.9 M
Total Other Income Expense Net-205.8 M-195.5 M
Net Loss-69.8 M-66.4 M
Net Income From Continuing Ops13.8 M13.1 M
Non Operating Income Net Other-12.2 M-11.6 M
Net Interest Income-113 M-118.6 M
Interest Income7.8 M6.7 M
Change To Netincome243.8 M256 M
Net Income Per Share 0.06  0.06 
Income Quality 21.85  22.94 
Net Income Per E B T 0.87  0.83 

Sabra Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Sabra Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sabra Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sabra Healthcare's important profitability drivers and their relationship over time.

Use Sabra Healthcare in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sabra Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sabra Healthcare will appreciate offsetting losses from the drop in the long position's value.

Sabra Healthcare Pair Trading

Sabra Healthcare REIT Pair Trading Analysis

The ability to find closely correlated positions to Sabra Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sabra Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sabra Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sabra Healthcare REIT to buy it.
The correlation of Sabra Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sabra Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sabra Healthcare REIT moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sabra Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sabra Healthcare position

In addition to having Sabra Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cars Thematic Idea Now

Cars
Cars Theme
Domestic and international companies involved in manufacturing and serving automobiles and trucks. The Cars theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cars Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
To fully project Sabra Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sabra Healthcare REIT at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sabra Healthcare's income statement, its balance sheet, and the statement of cash flows.
Potential Sabra Healthcare investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Sabra Healthcare investors may work on each financial statement separately, they are all related. The changes in Sabra Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sabra Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.